Significant Inflows Observed in ETFs - MLPX, ENB, TRP, KMI
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 05 2025
0mins
Should l Buy ENB?
Source: NASDAQ.COM
MLPX Share Price Analysis: MLPX's share price is currently at $61.73, with a 52-week low of $53.54 and a high of $67.47, indicating its performance within the trading range.
Understanding ETFs: Exchange traded funds (ETFs) function like stocks, where investors buy and sell "units" that can be created or destroyed based on demand, impacting the underlying assets.
Monitoring ETF Flows: Weekly analysis of shares outstanding helps identify ETFs with significant inflows (new units created) or outflows (units destroyed), which can affect the individual components of the ETFs.
Disclaimer on Views: The opinions expressed in the article are those of the author and do not necessarily represent the views of Nasdaq, Inc.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ENB?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ENB
Wall Street analysts forecast ENB stock price to fall
10 Analyst Rating
5 Buy
5 Hold
0 Sell
Moderate Buy
Current: 54.200
Low
45.79
Averages
53.54
High
69.00
Current: 54.200
Low
45.79
Averages
53.54
High
69.00
About ENB
Enbridge Inc. is an energy transportation and distribution company. The Company's segments include Liquids Pipelines, Gas Transmission, Gas Distribution and Storage, and Renewable Power Generation. Liquids Pipelines consists of pipelines and terminals in Canada and United States that transport and export various grades of crude oil and other liquid hydrocarbons, including the Mainline System, Regional Oil Sands System, Gulf Coast and Mid-Continent, and Other. Gas Transmission consists of its investments in natural gas pipelines and gathering and processing facilities in Canada and United States, including United States Gas Transmission, Canadian Gas Transmission, United States Midstream, and Other. Gas Distribution and Storage consists of its rate-regulated natural gas utility operations in Canada and United States. Renewable Power Generation consists primarily of investments in wind and solar assets, as well as equity interests in geothermal power and power transmission assets.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Earnings Expectations: Enbridge is set to announce its Q1 earnings on May 8, with Wall Street expecting an EPS of C$0.94 and revenue of C$18.54 billion, indicating stable performance in the energy infrastructure sector.
- Government Approval for Expansion: The Canadian government recently approved Enbridge's C$4 billion Sunrise expansion project, enhancing its market position in British Columbia's natural gas pipeline system, which is expected to drive future revenue growth.
- Market Performance: Over the past two years, Enbridge has beaten EPS estimates 88% of the time, although it has not exceeded revenue estimates, showcasing strong profitability despite revenue challenges.
- Stock Price Movement: Since the beginning of the year, Enbridge's shares have risen nearly 12%, outperforming the S&P 500's 7.6% increase, although the stock fell 1.3% on Thursday, with analysts maintaining a hold rating, reflecting cautious optimism about its future performance.
See More
- TransMedics' Bright Outlook: Despite TransMedics Group (NASDAQ: TMDX) reporting Q1 earnings per share of $0.30, below the expected $0.61, its revenue increased by 21% year-over-year, indicating strong long-term potential in organ transplant technology, especially with plans for European expansion.
- Rhythm Pharmaceuticals' Recovery: Rhythm Pharmaceuticals (NASDAQ: RYTM) recently secured FDA and European Commission approvals for Imcivree, which is expected to boost its stock price, while Japanese regulators are also reviewing the drug, impacting over 25,000 patients and highlighting significant market potential.
- Enbridge's Stable Returns: Enbridge (NYSE: ENB), as North America's largest natural gas utility, transports 30% of crude oil and one-fifth of natural gas, providing stable investment returns, with an attractive 5.2% dividend yield that stands out in the energy sector.
- Long-Term Growth Opportunities: Enbridge's management anticipates approximately $50 billion in growth opportunities by 2030, with investment decisions for $10 billion to $20 billion expected in the next 24 months, offering solid growth prospects despite being less explosive than TransMedics and Rhythm.
See More
- Election Results: At the Annual Meeting on May 6, 2026, Enbridge shareholders approved the election of all 12 nominated directors, with each receiving over 95% support, indicating strong shareholder confidence in the company's governance.
- Voting Details: The voting results revealed that M.M. (Mike) Ashar received 99.09% support, making him the most favored director, which underscores his significance and influence within the company.
- Strategic Direction: Enbridge remains committed to safely connecting energy supplies and investing in modern energy delivery infrastructure to ensure sustainable and affordable energy access, enhancing its competitiveness in North American and European markets.
- Technological Innovation: The company is advancing new technologies such as hydrogen, renewable natural gas, and carbon capture and storage, reflecting its strategic positioning in the renewable energy sector to adapt to global energy transition trends.
See More
- Election Results: At the 2026 Annual Meeting, Enbridge shareholders approved the election of all 12 nominated directors with a 99.09% approval rate, demonstrating strong shareholder confidence in the management team and solidifying their leadership position.
- Voting Details: The voting results revealed that M.M. (Mike) Ashar received over 1.22 billion votes in favor, with only 121,294 votes against, reflecting high shareholder endorsement of his leadership capabilities and providing a stable governance foundation for future strategic decisions.
- Company Background: Enbridge, headquartered in Calgary, is an energy company focused on the delivery of natural gas, oil, and renewable energy, boasting over a century of experience in conventional energy infrastructure and actively investing in modern energy delivery systems to ensure secure and affordable energy access.
- Future Directions: The company is advancing new technologies such as hydrogen, renewable natural gas, and carbon capture and storage, aiming to drive sustainability through innovation and enhance its competitive edge in the energy market.
See More
- Quarterly Dividend Announcement: Enbridge's Board of Directors has declared a quarterly dividend of $0.9700 per common share, payable on June 1, 2026, to shareholders of record on May 15, 2026, ensuring stable returns for shareholders and maintaining the company's financial health.
- Preferred Share Dividends: The Board also announced quarterly dividends for various preferred shares, including Series A at $0.34375 and Series B at $0.32513, all payable on the same date, demonstrating the company's commitment to different investor classes.
- Consistent Dividend Policy: The dividend amount remains consistent with the March 1, 2026 dividend, indicating the company's ability to sustain a stable dividend policy in the current economic environment, which enhances investor confidence and may attract more long-term investors.
- Company Background: Enbridge plays a crucial role in North American and European energy networks, focusing on investments in modern energy delivery infrastructure and advancing new technologies like hydrogen and carbon capture, reflecting its strategic positioning in the renewable energy sector.
See More
- AbbVie's Strong Financials: AbbVie, with a market cap of approximately $370 billion, generated over $61 billion in revenue last year and $20 billion in operating income, demonstrating its ability to grow despite patent expirations, while its 3.3% dividend yield significantly exceeds the S&P 500 average of 1.1%.
- Medtronic's Stability: Medtronic, valued at $101 billion, reported a 9% revenue increase in its latest quarter, with free cash flow of $5.4 billion easily covering its $3.6 billion annual dividend payout, resulting in a 3.6% yield, making it an ideal choice for income-focused investors.
- Enbridge's Consistent Growth: Enbridge, with a market cap of $119 billion, has raised its dividend for 31 consecutive years, with a recent 3% increase, yielding 5.2%, the highest among the listed stocks, and despite a payout ratio over 100%, its distributable cash flow indicates strong financial health.
- Diversified Investment Strategy: By investing in AbbVie, Medtronic, and Enbridge, investors can achieve monthly cash flow, leveraging the different dividend payment schedules of these companies to enhance the stability of their investment portfolio.
See More










